(MENAFN- GlobeNewsWire - Nasdaq) The following amendment has been made to the Issue of Equity and Total Voting Rights announcement released on 8 October 2021.
The nominal value of the shares has been corrected to read '£0.01'.
All other information remains unchanged.
The full amended text is shown below.
OCTOPUS AIM VCT PLC
8 October 2021
Issue of Equity and Total Voting Rights
Octopus AIM VCT plc (the“Company”) announces that 217,930 Ordinary Shares of £0.01 each were issued and allotted on 7 October 2021 (subject to Admission) at a price of 132.6p per share, equivalent to the current NAV of 125.3p grossed up by up to 5.5% (as set out in the Prospectus dated 19 August 2021) (the“Shares”). The Shares were issued and allotted on the same terms and conditions as set out in the Offer for Subscription to raise up to £30 million, issued jointly with Octopus AIM VCT 2 plc, with an over-allotment facility of £10 million, in the 2021/2022 and 2022/2023 tax years respectively (the“Offer”). However, on account of the Offer being full, the Shares were issued outside of the Offer.
Application for the new shares to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities has been made and dealings are expected to commence on or around 21 October 2021.
The issued share capital and total voting rights of the Company is now 162,319,908. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
For Octopus Company Secretarial Services Limited
020 3935 3803
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.